Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
10 hedge funds and large institutions have $94.9K invested in Petros Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.1% less ownership
Funds ownership: 0.21% → 0.12% (-0.1%)
17% less funds holding
Funds holding: 12 → 10 (-2)
42% less capital invested
Capital invested by funds: $165K → $94.9K (-$69.9K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$634 |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$458 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$35K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$31.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.07K |
| 4 |
BlackRock
New York
|
-$141 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$28 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $47.1K | – | – | – |
|
|
2
BlackRock
New York
| $24.4K | -$141 | -4 | -0.6% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $15.5K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $5.03K | -$8.07K | -229 | -63% |
|
|
EL
5
EMFO LLC
Weston,
Florida
| $1.48K | – | – | – |
|
|
6
Morgan Stanley
New York
| $753 | +$634 | +18 | +900% |
|
|
7
National Bank of Canada
Montreal,
Quebec, Canada
| $198 | +$458 | +13 | New |
|
|
NFSG
8
Newbridge Financial Services Group
Boca Raton,
Florida
| $178 | – | – | – |
|
9
Group One Trading
Chicago,
Illinois
| $117 | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $21 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $18 | – | – | – |
|
12
1832 Asset Management
Toronto,
Ontario, Canada
| $15 | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| $1 | – | – | – |
|
|
VF
14
Virtu Financial
New York
| – | -$35K | -993 | Closed |
|
|
SSA
15
Schonfeld Strategic Advisors
New York
| – | -$31.9K | -904 | Closed |
|
|
16
Fidelity Investments
Boston,
Massachusetts
| – | -$28 | -1 | Closed |
|
17
First Manhattan
New York
| – | -$14 | – | – |
|
PTPI Hedge Fund Activity: Q1 2024 in Review
10 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q1 2024, worth a combined $94.9K — down 42% from $165K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PTPI and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $634. The largest seller was Virtu Financial, exiting entirely with an estimated $35K sold.
- 10 institutional investors held Petros Pharmaceuticals (PTPI) as of Q1 2024, down from 12 in Q4 2023.
- Funds reported $94.9K of Petros Pharmaceuticals stock for Q1 2024, down 42% quarter-over-quarter.
- 1 fund opened new Petros Pharmaceuticals positions in Q1 2024 and 3 closed out, a net change of -2 holders.
- The largest Petros Pharmaceuticals buyer in Q1 2024 was Morgan Stanley, an estimated $634 added.
- The largest Petros Pharmaceuticals seller in Q1 2024 was Virtu Financial, an estimated $35K sold.
Based on aggregated 13F filings for Q1 2024.